Ptc Therapeutics (PTCT) Return on Equity (2013 - 2026)

Ptc Therapeutics' Return on Equity history runs 14 years deep, the most recent figure standing at 0.07% for Q1 2026.

• In Q1 2026, Return on Equity rose 8.0% year-over-year to 0.07%; the TTM figure through Mar 2026 stood at 0.07% (up 8.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity was 0.07% for Q1 2026 at Ptc Therapeutics, up from 0.03% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.12% in Q1 2022 to a low of 0.04% in Q3 2025.
• Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.01% in 2023.
• The sharpest annual moves came in 2022 and 2023: Return on Equity grew 12 bps in 2022, then decreased 10 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 0.02% in 2022, then plunged by 110 bps to 0.0% in 2023, then soared by 267 bps to 0.0% in 2024, then jumped by 766 bps to 0.03% in 2025, then soared by 140 bps to 0.07% in 2026.
• The last three Return on Equity figures came in at 0.07% (Q1 2026), 0.03% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.